These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 10430092)

  • 1. Alterations of the p16INK4a/p14ARF pathway in clear cell sarcoma.
    Takahira T; Oda Y; Tamiya S; Yamamoto H; Kawaguchi K; Kobayashi C; Iwamoto Y; Tsuneyoshi M
    Cancer Sci; 2004 Aug; 95(8):651-5. PubMed ID: 15298727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk.
    Sherborne AL; Hosking FJ; Prasad RB; Kumar R; Koehler R; Vijayakrishnan J; Papaemmanuil E; Bartram CR; Stanulla M; Schrappe M; Gast A; Dobbins SE; Ma Y; Sheridan E; Taylor M; Kinsey SE; Lightfoot T; Roman E; Irving JA; Allan JM; Moorman AV; Harrison CJ; Tomlinson IP; Richards S; Zimmermann M; Szalai C; Semsei AF; Erdelyi DJ; Krajinovic M; Sinnett D; Healy J; Gonzalez Neira A; Kawamata N; Ogawa S; Koeffler HP; Hemminki K; Greaves M; Houlston RS
    Nat Genet; 2010 Jun; 42(6):492-4. PubMed ID: 20453839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Epigenetic Age and p16INK4a With Markers of T-Cell Composition in a Healthy Cohort.
    Burd CE; Peng J; Laskowski BF; Hollyfield JL; Zhang S; Fadda P; Yu L; Andridge RR; Kiecolt-Glaser JK
    J Gerontol A Biol Sci Med Sci; 2020 Nov; 75(12):2299-2303. PubMed ID: 32361724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of CDKN2A/B deletions in acute lymphoblastic leukaemia: a meta-analysis.
    Zhang W; Kuang P; Liu T
    Ann Med; 2019 Feb; 51(1):28-40. PubMed ID: 30592434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDKN2 Gene Deletion as Poor Prognosis Predictor Involved in the Progression of Adult B-Lineage Acute Lymphoblastic Leukemia Patients.
    Xu N; Li YL; Zhou X; Cao R; Li H; Lu QS; Li L; Lu ZY; Huang JX; Sun J; Liu QF; Du QF; Liu XL
    J Cancer; 2015; 6(11):1114-20. PubMed ID: 26516359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy in malignant transformation and cancer progression.
    Galluzzi L; Pietrocola F; Bravo-San Pedro JM; Amaravadi RK; Baehrecke EH; Cecconi F; Codogno P; Debnath J; Gewirtz DA; Karantza V; Kimmelman A; Kumar S; Levine B; Maiuri MC; Martin SJ; Penninger J; Piacentini M; Rubinsztein DC; Simon HU; Simonsen A; Thorburn AM; Velasco G; Ryan KM; Kroemer G
    EMBO J; 2015 Apr; 34(7):856-80. PubMed ID: 25712477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic targets in the ARF tumor suppressor pathway.
    Saporita AJ; Maggi LB; Apicelli AJ; Weber JD
    Curr Med Chem; 2007; 14(17):1815-27. PubMed ID: 17627519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, deletion [was deleton] and mutation of p16 gene in human gastric cancer.
    He XS; Su Q; Chen ZC; He XT; Long ZF; Ling H; Zhang LR
    World J Gastroenterol; 2001 Aug; 7(4):515-21. PubMed ID: 11819820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitors of cyclins/CDK of the 9p21 chromosomal region and malignant hemopathies].
    Quesnel B
    Bull Cancer; 1998 Sep; 85(9):747-54. PubMed ID: 9817058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16ink4a gene and hematological malignancies.
    Quesnel B; Preudhomme C; Fenaux P
    Leuk Lymphoma; 1996 Jun; 22(1-2):11-24. PubMed ID: 8724524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
    Faderl S; Kantarjian HM; Manshouri T; Chan CY; Pierce S; Hays KJ; Cortes J; Thomas D; Estrov Z; Albitar M
    Clin Cancer Res; 1999 Jul; 5(7):1855-61. PubMed ID: 10430092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemia.
    Faderl S; Estrov Z; Kantarjian HM; Thomas D; Cortes J; Manshouri T; Chan CC; Hays KJ; Pierce S; Albitar M
    Cytokines Cell Mol Ther; 1999 Sep; 5(3):159-63. PubMed ID: 10641574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma.
    Xing EP; Nie Y; Song Y; Yang GY; Cai YC; Wang LD; Yang CS
    Clin Cancer Res; 1999 Oct; 5(10):2704-13. PubMed ID: 10537333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.
    Flores JF; Walker GJ; Glendening JM; Haluska FG; Castresana JS; Rubio MP; Pastorfide GC; Boyer LA; Kao WH; Bulyk ML; Barnhill RL; Hayward NK; Housman DE; Fountain JW
    Cancer Res; 1996 Nov; 56(21):5023-32. PubMed ID: 8895759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia.
    Okuda T; Shurtleff SA; Valentine MB; Raimondi SC; Head DR; Behm F; Curcio-Brint AM; Liu Q; Pui CH; Sherr CJ
    Blood; 1995 May; 85(9):2321-30. PubMed ID: 7727766
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.